Bienvenue dans votre Espace

    Découvrez les dernières actualités et naviguez avec le sous-menu.

    Capture d’écran 2016-03-14 à 15.32.21


      OCR the company revolutionising the selection of effective drug candidates for cancer, raises €1.25m from Newfund, NFA and the management team in order to accelerate its growth.

    • LILLE, 16TH JULY 2015

      OCR and Pierre Fabre’s Phase I Clinical Pharmacology Study published in prestigious Clinical Cancer Research journal.

    • LILLE, O2ND APRIL 2015

      OCR and Ecrins Therapeutics initiate €1.9m “Dog to Man” pioneering translational research programme to advance human and vet oncology treatment.

    • LILLE, 23RD MARCH 2015

      OCR and PRISM announce ground-breaking research collaboration to advance real-time diagnosis using mass spectrometry.

    • LILLE, 30TH JANUARY 2015

      OCR strengthens veterinary and R&D expertise to respond to the needs of the pharmaceutical industry.